New York State Psychiatric Institute
Clinical trials sponsored by New York State Psychiatric Institute, explained in plain language.
-
New hope: clozapine may curb violence in schizophrenia patients
Disease control Recruiting nowThis study tests whether clozapine, a medication for schizophrenia, can lower the risk of violent acts better than usual antipsychotic treatments. About 280 adults with schizophrenia or schizoaffective disorder who have been violent in the past six months will take either clozapi…
Phase: PHASE4 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated May 01, 2026 20:26 UTC
-
Opioid vaccine trial aims to block drug high and curb relapse
Disease control Recruiting nowThis study tests a vaccine designed to help people with opioid use disorder by training the body to produce antibodies that bind to oxycodone in the blood, reducing its ability to reach the brain and cause a high. The trial involves 45 adults aged 18 to 59 and will check for safe…
Phase: PHASE1, PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Cash for moms: can $40 a month boost kids' brain health?
Knowledge-focused Recruiting nowThis study looks at whether giving mothers in Brazil extra cash each month can protect their children's brain development and mental health. About 450 families with children ages 7-10 will be randomly assigned to receive either a high ($40/month) or low ($2/month) cash supplement…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC